JP2022525456A5 - - Google Patents
Info
- Publication number
- JP2022525456A5 JP2022525456A5 JP2021555534A JP2021555534A JP2022525456A5 JP 2022525456 A5 JP2022525456 A5 JP 2022525456A5 JP 2021555534 A JP2021555534 A JP 2021555534A JP 2021555534 A JP2021555534 A JP 2021555534A JP 2022525456 A5 JP2022525456 A5 JP 2022525456A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- slc39a5
- nucleotide sequence
- nucleic acid
- complement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962818811P | 2019-03-15 | 2019-03-15 | |
| US62/818,811 | 2019-03-15 | ||
| US202062976716P | 2020-02-14 | 2020-02-14 | |
| US62/976,716 | 2020-02-14 | ||
| PCT/US2020/022251 WO2020190608A2 (en) | 2019-03-15 | 2020-03-12 | Treatment of hyperglycemia with solute carrier family 39 member 5 (slc39a5) inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022525456A JP2022525456A (ja) | 2022-05-16 |
| JP2022525456A5 true JP2022525456A5 (https=) | 2023-03-14 |
| JP7575396B2 JP7575396B2 (ja) | 2024-10-29 |
Family
ID=70190174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021555534A Active JP7575396B2 (ja) | 2019-03-15 | 2020-03-12 | 溶質キャリアファミリー３９メンバー５（ｓｌｃ３９ａ５）阻害剤を用いた高血糖の処置 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12083141B2 (https=) |
| EP (1) | EP3938513A2 (https=) |
| JP (1) | JP7575396B2 (https=) |
| KR (1) | KR20210139322A (https=) |
| CN (1) | CN113677368A (https=) |
| AU (1) | AU2020241502B2 (https=) |
| CA (1) | CA3132985A1 (https=) |
| IL (1) | IL286308A (https=) |
| MX (1) | MX2021011015A (https=) |
| NZ (1) | NZ780568A (https=) |
| SG (1) | SG11202109711WA (https=) |
| WO (1) | WO2020190608A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200288683A1 (en) * | 2019-03-15 | 2020-09-17 | Regeneron Pharmaceuticals, Inc. | Loss of function rodent model of solute carrier 39 member 5 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19830770C1 (de) | 1998-07-09 | 2000-05-18 | Sueddeutsche Kalkstickstoff | Wasserlösliche Zinkpyruvate bzw. deren Hydrate, Verfahren zu ihrer Herstellung und deren Verwendung |
| JP2001220348A (ja) | 1999-11-30 | 2001-08-14 | Japan Science & Technology Corp | 亜鉛（ｉｉ）有機錯体からなる血糖降下剤 |
-
2020
- 2020-03-12 CA CA3132985A patent/CA3132985A1/en active Pending
- 2020-03-12 SG SG11202109711W patent/SG11202109711WA/en unknown
- 2020-03-12 NZ NZ780568A patent/NZ780568A/en unknown
- 2020-03-12 EP EP20717451.7A patent/EP3938513A2/en active Pending
- 2020-03-12 KR KR1020217032315A patent/KR20210139322A/ko active Pending
- 2020-03-12 WO PCT/US2020/022251 patent/WO2020190608A2/en not_active Ceased
- 2020-03-12 AU AU2020241502A patent/AU2020241502B2/en active Active
- 2020-03-12 CN CN202080027032.4A patent/CN113677368A/zh active Pending
- 2020-03-12 JP JP2021555534A patent/JP7575396B2/ja active Active
- 2020-03-12 MX MX2021011015A patent/MX2021011015A/es unknown
- 2020-03-12 US US16/816,515 patent/US12083141B2/en active Active
-
2021
- 2021-09-12 IL IL286308A patent/IL286308A/en unknown
-
2024
- 2024-08-08 US US18/798,198 patent/US20250032529A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022523301A5 (https=) | ||
| AU2009240021B2 (en) | Antiviral therapy | |
| JP2006517092A (ja) | 心不全遺伝子の決定及び治療薬スクリーニング | |
| EP3873487A2 (en) | A quantitative algorithm for endometriosis | |
| Lee et al. | Dinucleotide repeat polymorphism in intron II of human Toll‐like receptor 2 gene and susceptibility to rheumatoid arthritis | |
| CN115066505A (zh) | 生物标记物及其在治疗慢性乙型肝炎感染中的用途 | |
| Granel et al. | Association between a CTGF gene polymorphism and systemic sclerosis in a French population | |
| JP2022525456A5 (https=) | ||
| CN106661618B (zh) | Dna甲基化状态作为酒精使用和戒酒的生物标志物 | |
| JP2022525545A5 (https=) | ||
| JP2009511026A (ja) | 血栓塞栓性及び冠状動脈性心疾患の診断方法 | |
| JP4242590B2 (ja) | 慢性関節リウマチの疾患感受性遺伝子、及びその利用 | |
| US20030032099A1 (en) | Methods for predicting susceptibility to obesity and obesity-associated health problems | |
| JP2022515838A5 (https=) | ||
| JP6017117B2 (ja) | 炎症性腸疾患患者におけるアザチオプリン（ａｚｔ）の血中濃度の安定性を予測するジェネティックバイオマーカー | |
| CN101243193A (zh) | 半胱氨酸双加氧酶中的多态性 | |
| EP1716171A1 (en) | IDENTIFICATION OF SNPs ASSOCIATED WITH HYPERLIPIDEMIA, DYSLIPIDEMIA AND DEFECTIVE CARBOHYDRATE METABOLISM | |
| JP2024536001A5 (https=) | ||
| JP2022544393A (ja) | マクロファージ刺激１受容体（ｍｓｔ１ｒ）バリアント及びその使用 | |
| JP2022525546A5 (https=) | ||
| JP4317376B2 (ja) | 糖尿病性腎症遺伝子の検出方法 | |
| JP4444576B2 (ja) | ２型糖尿病関連遺伝子 | |
| RU2021129890A (ru) | Лечение гипергликемии с помощью ингибиторов члена 5 семейства 39 транспортеров растворенных веществ (slc39a5) | |
| CN118265529A (zh) | 使用camp应答元件结合蛋白3样3(creb3l3)抑制剂的肝病治疗 | |
| CN121175436A (zh) | 用压电式机械敏感离子通道组分1(piezo1)激动剂治疗静脉曲张 |